Buscar en
Revista Colombiana de Psiquiatría
Toda la web
Inicio Revista Colombiana de Psiquiatría Stress, Resilience, Moral Distress, and Depression–Anxiety Among Oncology Care...
Información de la revista
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
51
Original article
Acceso a texto completo
Disponible online el 21 de Julio de 2023
Stress, Resilience, Moral Distress, and Depression–Anxiety Among Oncology Care Providers in Colombia During the COVID-19 Pandemic
Estrés, resiliencia, angustia moral y depresión/ansiedad entre los proveedores de atención oncológica en Colombia durante la pandemia de COVID-19
Visitas
51
Nicolás Martineza, María del Pilar Garcíab, Timothy P. Hannac, Claudio N. Soaresc, Miguel Uribea, Richard Sullivand, Christopher Boothc, Raúl Murilloa,b,
Autor para correspondencia
rmurillo@husi.org.co

Corresponding author.
a Pontificia Universidad Javeriana, Bogotá, Colombia
b Hospital Universitario San Ignacio, Bogotá, Colombia
c Queen's University, Kingston, Canada
d King's College London, London, UK
Este artículo ha recibido
Recibido 10 abril 2023. Aceptado 22 junio 2023
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (5)
Table 1. Socio-demographic and baseline occupational characteristics.
Table 2. Average PSS, CDRS, and PHQ-4 scores compared to baseline characteristics of the study population.
Table 3. Perceived sources of stress during the COVID-19 pandemic.
Table 4. Bivariate analysis of the association between high PHQ-4 score (≥6) and baseline characteristics of the study population.
Table 5. Multivariate analysis of the predictor variables for a high PHQ-4 score (≥6).
Mostrar másMostrar menos
Material adicional (1)
Abstract
Objective

To describe the impact of COVID-19 on oncology care providers’ self-reported perceived stress, resilience, moral distress, anxiety, and depression in Colombia.

Methods

During 2020, a cross-sectional survey was carried out among oncology care providers. The Perceived Stress Scale, Connor–Davidson Resilience Scale, Moral Distress Thermometer, and the PHQ-4 were used. Basic socio-demographic and occupational characteristics are described, and bivariate and multivariate analyses were done to investigate their association with a high PHQ-4 score (>6).

Results

148 participants (mean age 43.1 years, 54.6% women, 72.3% medical specialists) were recruited. The major source of stress was not being infected, but spreading COVID-19. A low prevalence of depression/anxiety was found, as well as low resilience and moral distress. Women reported lower resilience and higher depression/anxiety. History of depression and lack of adequate coping strategies were associated with higher levels of depression/anxiety.

Conclusions

The impact of the COVID-19 pandemic on the mental health of oncology care providers was mild, probably due to the protection for oncology patients during this period; however, women reported a greater impact. The association of demographic and clinical variables with higher levels of depression/anxiety should inform further preventive measures to reduce the impact of prolonged public health crises on healthcare providers’ mental health.

Keywords:
COVID-19
Oncology service
Hospital
Health personnel/psychology
Mental health
Colombia
Resumen
Objetivo

Describir el impacto del COVID-19 en el estrés, la resiliencia, el sufrimiento moral, la ansiedad y la depresión percibidos por los proveedores de atención oncológica en Colombia.

Métodos

Durante el año 2020 se realizó una encuesta entre prestadores de atención oncológica. Se utilizaron la escala de estrés percibido, la escala de resiliencia de Connor-Davidson, el termómetro de angustia moral y el PHQ-4. Se describen las características sociodemográficas y ocupacionales básicas, y se realizaron análisis bivariados y multivariados para investigar su asociación con una puntuación alta de PHQ-4 (>6).

Resultados

Se reclutaron 148 participantes (edad media 43.1 años, el 54.6% mujeres y el 72.3% médicos especialistas). La principal fuente de estrés no era estar infectado, sino propagar el COVID-19. Se encontró baja prevalencia de depresión/ansiedad, baja resiliencia y angustia moral. Las mujeres reportaron menor resiliencia y mayor depresión/ansiedad. Los antecedentes de depresión y la falta de estrategias de afrontamiento adecuadas se asociaron con niveles más altos de depresión/ansiedad.

Conclusiones

El impacto de la pandemia de COVID-19 en la salud mental de los proveedores de atención oncológica fue leve, probablemente debido a la protección de los pacientes oncológicos durante este período; sin embargo, las mujeres reportaron un mayor impacto. La asociación de variables demográficas y clínicas con niveles más altos de depresión/ansiedad debería reportar medidas preventivas adicionales para reducir el impacto de las crisis de salud pública prolongadas en la salud mental de los proveedores de atención médica.

Palabras clave:
COVID-19
Servicio de oncología
Hospital
Personal de salud/psicología
Salud mental
Colombia
Texto completo
Introduction

During the COVID-19 pandemic, healthcare providers experienced several unexpected stressors due to the threat to quality of care by challenges, such as the inability to provide usual standards, the abrupt implementation of new guidelines, the uncertainty about the safety and efficacy of remote care for patients frequently isolated, and fears of acquired infection and infecting their families.

Some studies have found that the COVID-19 pandemic is associated with significant long-term stress, but not mental illness in healthcare providers.1 Other studies found that hospital workers treating SARS-Cov2-infected patients reported significantly higher levels of burnout and psychological distress. Consequently, these hospital workers reduced patient contact and work hours quicker.2

In the oncology care setting, additional stressors include competing demand for resources with COVID-19 care, the high mortality rate among oncology patients with COVID-19,3 and balancing the risks of SARS-Cov2 infection against the benefits of cancer therapies that might compromise patient immunity or cause illness due to exposure to the hospital environment. Furthermore, oncology care providers were under the same everyday stressors as the general population, including providing child and elderly care, insufficient family and leisure activities outside the home, and social isolation.

How oncology providers face these challenges varies broadly according to factors such as their primary role in oncology care and the type of practice. Several studies have reported the impact of the COVID-19 pandemic on the wellbeing and mental health of radiation oncologists, haemato-oncologists, oncology surgeons, oncology nurses, radiotherapists, and other workers in the oncology healthcare team4–9; however, the response to stress also depends on the context, including general socioeconomic conditions and characteristics of the health systems. Despite potential differences among countries, given their unique contextual characteristics, most studies have been conducted in high-income countries. To our knowledge, only Brazil has been included in an international survey on anxiety among oncologists due to the pandemic and we also found only one publication (also in Brazil) about the psychosocial impact of the COVID-19 pandemic on oncology nursing.10

Our study aimed at quantifying and describing the impact of COVID-19 on oncology care providers as levels of perceived stress, resilience, moral distress, anxiety, and depression in Colombia, a middle-income country in South America with universal health insurance coverage.

Methods

The first COVID-19 case was reported in Colombia during late March 2020. The lockdown started on March 27th and lasted until August 30th after the end of the first pandemic wave. We conducted a cross-sectional survey of oncology care providers, including medical specialists, nurses, and psychologists. Between May and November 2020, an online questionnaire was distributed among affiliates to the following scientific societies: Haemato-Oncology (ACHO), Radiation Oncology (ACRO), Palliative Care (ASOCUPAC), Oncology Nursing (AEOC), and Oncology and Palliative Care (REPSOCUP).

Four key dimensions of mental health were selected for assessment with the following brief inventory strategies: Perceived Stress Scale (PSS),11 Connor–Davidson Resilience Scale (CDRS),12 Moral Distress Thermometer (MDT),13 and the four-item Patient Health Questionnaire for Anxiety and Depression (PHQ-4).14 The internal consistency of PSS, CDRS, and PHQ-4 was evaluated by McDonald's-omega (ω) and Cronbach's-alpha (α) indices. In addition, a correlation analysis between scales was carried out using Spearman's rank order test with a 0.01 significance level.

The only exclusion criterion was having worked for less than a year in oncology care. For the study, the measurement instruments were translated into Spanish with a contrast back translation to English to verify the fidelity of the content and ensure its understandability. This study was presented and approved by the ethics committee of the University Hospital San Ignacio (FM-CIE-0471-20).

Data analysis

The data were analyzed using SPSS 24. Stress, resilience, moral distress, anxiety, and depression were managed as separate outcome variables, and their association with socio-demographic characteristics and working conditions was assessed.

For the PSS, each of the four stress sources was rated on a 5-point Likert scale to measure the responses. The median score on each scale item was determined independently. Additionally, a total score was determined in the range of 0–40, in which a higher score indicates a higher stress level.11

For the CDRS, a global score was calculated from a range of 0 to 40, with scores near 40 representing higher resilience levels and scores equal to or below 29 interpreted as low.15 A point scale from 0 to 10 was used for the MDT; scores equal to or higher than 4 were considered high.16 The PHQ-4 scores are operationally categorized as low (scores 0–2), mild (scores 3–5), moderate (scores 6–8), and severe (scores 9–12).14

Frequencies and proportions were estimated to describe socio-demographic and baseline occupational characteristics. Description of outcomes as categorical variables was done by type of care provider (nurse, medical specialist, psychologist), time in oncology care (working experience in years), city of practice (Bogotá and others), and type of center (comprehensive and non-comprehensive). The Shapiro–Wilk normality test was used to analyze the distribution, and the Kruskal–Wallis test was used for comparisons if the abnormal distribution was present, defining a significance cut-off value of 0.05. The McDonald's-ω and Cronbach's-α indices were calculated as internal consistency and reliability estimates.

In addition to the comparisons by categories, as previously described, a measure of binary association for the PHQ-4 and socio-demographic characteristics was done by estimating the OR and a multivariate logistic regression model (enter method) adjusted binary associations if potential variables in the univariate analysis revealed a p-value<0.2.

Results

In total, 148 health professionals answered the survey, the majority corresponding to medical specialists (72.3%) without significant differences by sex. The mean age was 43.1 years, and most respondents were from Bogotá (56.8%) (Table 1).

Table 1.

Socio-demographic and baseline occupational characteristics.

Variables  n (%)  Variables  n (%) 
SexAge
Men  66 (44.6)  Mean=43.1   
Women  81 (54.7)  Min=24 Max=74   
Missing  1 (0.7)     
City of practicePost-graduate training
Bogota  84 (56.8)  Yes  96 (64.9) 
Other  63 (42.4)  No  51 (34.5) 
Missing  1 (0.67)  Missing  1 (0.67) 
Care providerWorking experience
Medical specialist  107 (72.3)  0–5  41 (27.7) 
Nurse  20 (13.5)  6–15  57 (38.5) 
Psychologist  17 (11.5)  16–30  34 (22.9) 
Others  4 (2.7)  >30  16 (10.8) 
Marital statusWorkplace
Single  41 (27.7)  Comprehensive cancer center  113 (76.4) 
Married  90 (60.8)  Non-comprehensive cancer center  33 (22.3) 
Divorced  17 (11.5)  Missing  2 (1.4) 
Number of practice centersType of cancer care delivery
One  103 (69.6)  Ambulatory  62 (41.9) 
Two  35 (23.6)  In-hospital  35 (23.6) 
More than two  10 (6.8)  Both  49 (33.1) 
    Missing  2 (1.4) 
Covid-19 diagnosisAdequate coping strategies
Yes  33 (22.3)  Not at all  22 (14.9) 
No  115 (77.7)  Few  47 (31.8) 
History of depressionOften  47 (31.8) 
Yes  9 (6.1)  Usually  32 (21.6) 
No  138 (93.2)     
Missing  1 (0.7)     

The results of the Shapiro–Wilk normality test showed that the PSS, CDRS, MDT, and PHQ-4 variables had an abnormal distribution (p<0.05). Consequently, the Kruskal–Wallis test was used to establish comparisons between the psychological variables and the socio-demographic variables.

There was a moderate level of perceived stress with average values ranging from 14 to 16 among socio-demographic and occupational characteristics (Table 2), the exception being 12.5 (low level of stress) for care providers, as they usually have adequate coping strategies. Care providers also reported the highest resilience (CDRS) score (32.4) among the defined categories. However, care providers other than physicians, nurses, or psychologists reported the lowest PSS and MDT scores and the highest resilience (CDRS) score.

Table 2.

Average PSS, CDRS, and PHQ-4 scores compared to baseline characteristics of the study population.

Variables  n (%)  PSSCDRSMDPHQ-4
    Mean  p-Value  Mean  p-Value  Mean  p-Value  Mean  p-Value 
Sex
Men  44.6  14.2  0.3232.3  0.013.7  0.902.4  0.04
Women  54.7  15.5  30.0  3.7  3.4 
City of practice
Bogota  56.8  15.5  0.2730.6  0.543.6  0.403.2  0.70
Other  42.4  14.1  31.7  3.8  2.7 
Marital status
Single  27.7  15.0  0.7429.9  0.753.7  0.702.9  0.61
Married  60.8  14.6  31.5  3.6  3.0 
Divorced  11.5  15.8  32.4  4.0  3.3 
Care provider
Medical specialist  72.3  15.0  0.0831.6  0.193.8  0.263.1  0.04
Nurse  13.5  14.7  24.5  3.6  2.3 
Psychologist  11.5  14.2  30.7  3.8  2.7 
Other  2.7  8.0  34.8  1.3  0.0 
Working experience
0–5  27.7  14.5  0.9931.6  0.943.6  0.472.8  0.76
6–15  38.5  15.2  30.7  3.4  3.2 
16–30  22.9  15.0  31.1  4.1  2.8 
>30  10.8  14.4  31.2  4.1  2.9 
Workplace
Comprehensive cancer center  76.4  14.5  0.0731.5  0.443.5  0.422.9  0.71
Non-comprehensive cancer center  22.3  16.3  30.0  4.0  3.0 
COVID-19 diagnosis
Yes  22.3  13.7  0.1232.5  0.303.1  0.142.4  0.14
No  77.7  15.2  30.7  3.8  3.1 
History of depression
Yes  6.8  22.2  0.0026.9  0.105.8  0.027.0  0.00
No  93.2  14.3  31.4  3.5  2.7 
Adequate coping strategies
Not at all  14.9  18.0  0.0129.1  0.154.4  0.494.3  0.06
Few  31.8  14.9  31.4  3.7  3.4 
Often  31.8  15.0  30.7  3.6  2.8 
Usually  21.6  12.5  32.4  3.3  1.8 
Internal consistencyω=0.91 α=0.91ω=0.93 α=0.91NAω=0.91 α=0.89

Note: PSS=Perceived Stress Scale: scores27 are considered high, CDRS=The Connor–Davidson Resilience Scale: scores29 are considered low, MD=Moral Distress Thermometer: scores4 are considered high, PHQ-4=Anxiety and Depression Screen: scores9 are interpreted as high or severe, ω=McDonald's-omega, α=Cronbach's-alpha.

Bold letters indicate a significant p value.

Regarding resilience (CDRS), nurses reported the lowest score (24.5), but significant differences were found between men and women (Table 2). However, we found no significant differences between socio-demographic and occupational characteristics, although providers reported not having any adequate coping strategy, and those with 16 or more years of experience reported an MDT score over 4. Concerning the PHQ-4, all categories showed normal to low anxiety–depression levels (scores under 6).

The major stressor was the risk of spreading COVID-19; however, for care providers with working experience between 16 and 30 years and 30 years and over, the major stressors were the working environment and the risk of SARS-Cov2 infection, respectively (Table 3). In all cases, the source of stress with the lowest score was having children at home. Internal consistency indices for this scale were ω=0.79 and α=0.69, thus showing good reliability.

Table 3.

Perceived sources of stress during the COVID-19 pandemic.

Variables  n (%)  WE  PC  SCI  SC  SI  FC  Ch 
Sex
Men  44.6  2.2  1.8  2.5  2.6  1.8  2.0  0.9 
Women  54.7  2.4  2.0  2.4  2.7  1.7  1.8  0.9 
City of practice
Bogotá  56.8  2.4  2.0  2.5  2.8  1.6  1.9  0.9 
Others  42.4  2.1  1.8  2.4  2.5  1.8  1.8  0.8 
Marital status
Single  27.7  2.3  1.8  2.4  2.9  1.6  1.7  0.2 
Married  60.8  2.2  1.8  2.5  2.6  1.7  1.9  1.0 
Divorced  11.5  2.7  2.5  2.4  2.5  2.1  1.9  1.4 
Care provider
Medical specialist  72.3  2.3  2.00  2.4  2.6  1.8  1.9  0.9 
Nurse  13.5  2.5  1.7  2.9  3.3  2.0  2.0  0.8 
Psychologist  11.5  2.2  1.8  2.3  2.4  1.4  1.4  0.7 
Others  2.7  2.5  1.5  1.0  3.0  0.8  2.0  1.0 
Working experience
0–5  27.7  2.3  1.8  2.5  2.7  1.8  2.0  0.4 
6–15  38.5  2.5  2.1  2.5  3.1  1.6  1.6  1.3 
16–30  22.9  2.3  1.9  2.3  2.3  1.8  2.0  0.8 
>30  10.8  1.6  1.6  2.4  2.3  1.5  2.1  0.4 
Workplace
Comprehensive cancer center  76.4  2.3  2.0  2.4  2.7  2.7  1.6  1.8 
Non-comprehensive cancer center  22.3  2.3  1.6  2.4  2.6  2.0  1.9  1.2 
COVID-19 diagnosis
Yes  22.3  2.2  2.0  2.8  2.8  1.6  1.3  0.8 
No  77.7  2.3  1.9  2.3  2.7  1.7  2.0  0.9 
History of depression
Yes  6.8  2.4  2.6  2.8  3.3  1.9  3.0  0.4 
No  93.2  2.3  1.9  2.4  2.6  1.7  1.8  0.9 
Adequate coping strategies
Not at all  14.9  2.6  2.2  2.9  3.1  1.9  2.2  1.0 
Few  31.8  2.3  2.1  2.7  2.7  2.0  2.1  1.0 
Often  31.8  2.3  2.0  2.3  2.5  1.5  1.6  0.8 
Usually  21.6  2.1  1.3  1.9  2.7  1.5  1.7  0.7 

WE=working environment, PC=patient care, SCI=SARS-Cov2 infection, SC=spreading COVID-19, SI=social isolation, FC=financial concerns, Ch=having children at home. The underlined numbers are the highest outcomes of every socio-demographic characteristic.

Correlations between all scales were statistically significant (Supplementary Table 2), and all measures revealed optimal reliability (indices>0.80); yet, no measure of internal consistency was done for MDT given the single measure (moral distress) of this scale.

In the bivariate analysis sex, COVID-19 diagnosis, history of depression, and adequate coping strategies showed a p-value<0.2 and were included in the multivariate analysis (Table 4). Only a history of depression showed a significant direct association with high PHQ-4 scores (score6, OR 7.4, 95% CI 1.8–29.8), and the perception of adequate coping strategies showed a significant inverse association (Table 4).

Table 4.

Bivariate analysis of the association between high PHQ-4 score (≥6) and baseline characteristics of the study population.

Variable  OR  95% CI  p-Value 
Sex
Men  –  0.9–6.2  0.06 
Women  2.4     
City of practice
Other  –  –  0.21 
Bogota  1.8  0.7–4.4   
Marital status
Single  –  –  0.64 
Married  1.7  0.6–4.9   
Divorced  0.9  0.3–7.3   
Care providera
Nurse  –  –  0.79 
Medical specialist  0.5  0.2–1.5   
Working experience
0–5  –  –  0.88 
6–15  1.7  0.5–5.3   
16–30  1.6  0.4–5.8   
>30  1.7  0.4–8.0.95   
Workplace
Comprehensive cancer center  –  –  0.82 
Non-comprehensive cancer center  0.9  0.3–2.6   
Number of practice centers
One  –  –  0.46 
Two  0.5  0.2–1.7   
More than two  0.5  0.1–3.9   
COVID-19 diagnosis
No    0.06 
Yes  0.8  0.3–2.5   
History of depression
No  –  –  0.00 
Yes  7.4  1.8–29.8   
Adequate coping strategies
Usually  –  –  0.00 
Often  2.1  0.0–21.32   
Few  9.5  1.2–77.6   
Not at all  25.8  3.0–224.2   

Note: OR=odd ratio, CI=confidence intervals.

a

Psychologists did not have high scores in the PHQ-4.

Bold letters indicate a significant p value.

In the multivariate model, only sex (woman), history of depression, and having few or no adequate coping strategies were significantly associated with a high PHQ-4 score (Table 5).

Table 5.

Multivariate analysis of the predictor variables for a high PHQ-4 score (≥6).

Variables  OR  95% CI  p-Value 
Sex (woman)  3.4  1.2–10.1  0.03 
History of depression  6.6  1.2–37.3  0.03 
Covid-19 diagnosis  1.1  0.3–3.7  0.88 
Adequate coping strategies
Usually  –  –  – 
Often  1.7  0.2–17.6  0.67 
Few  8.9  1.1–75.3  0.05 
Not at all  25.0  2.7–231.1  0.01 

Bold letters indicate a significant p value.

Discussion

Several studies have examined the impact of COVID-19 on mental health among healthcare workers17–22; however, only a few studies have been conducted in low- and middle-income countries (LMIC). To our knowledge, this is the first study of oncology care providers from Latin America to specifically assess the psychological impact of the COVID-19 pandemic.

We found spreading COVID-19 instead of getting infected as the major sources of stress except for those with longer working experience (30 years and over); the latter may be related to their higher risk for complications given their older age (Table 3). In general, studies among healthcare providers have shown a personal sense of higher responsibility for preventing the spread of the virus.23–27 Other studies have also found that financial concerns and other stressors, not COVID-19 infection, are the major source of distress19,28; however, most were carried out among the general population and were not specific to healthcare workers or other occupations.

Financial concerns as a source of stress among oncology care providers in our study are interesting and might reflect either the type of employment with no stable relationship with their respective institutions or a high dependency for family income beyond their own employment, both factors that could be different from high-income countries. Previous studies from Latin America, including healthcare providers, but not specifically oncology care, have found relevant differences by type of provider (doctors versus others)29; however, we did not find such differences in our study.

A low prevalence of depression and anxiety, low levels of moral distress, and normal levels of resilience were observed in our study (Table 2). In contrast, reports of Latin American healthcare workers were not consistent, showing higher levels of anxiety and depression in Chilean populations,30 but lower levels in Peruvian populations29 and among Hispanic American otolaryngologists.31 Oncology care providers regularly have a higher psychological burden,32–34 thus resulting in a more frequent manifestation of anxiety and depression35,36; however, it is possible that during the pandemic, following its sudden onset, common exposure to acute stressors induces a similar response among all healthcare workers without major distinctions by specialty or level of training.23,37,38

Moral distress occurs when a person cannot act the way they believe is ethically appropriate.39 Care providers with longer working experience, divorcees, those working in non-comprehensive centers, and those without coping strategies reported high levels of moral distress (Table 2); however, only a history of depression showed a statistically significant increase. Oncology care was prioritized in Colombia during the pandemic, and ethical dilemmas, such as deferring treatment, changing protocols, and referrals to intensive care units, were faced on a case-by-case basis at institutions by following national and international consensus guidelines without placing a great burden on individuals for decisions.

Significant differences were observed between women and men regarding resilience and depression/anxiety with higher and lower scores for the latter, respectively. Although previous studies have shown higher resilience among Latin American women,40 the impact of the COVID-19 pandemic and working and work/life disparities for women in a society without gender equity should also be considered as possible factors explaining the difference in our study. In addition, women regularly have a higher prevalence of depression/anxiety,41–44 and unlike resilience, the COVID-19 pandemic worsened the wellbeing of women, a finding already reported in health workers from Latin America.29

In Colombia, in common with the rest of Latin America, most nurses are women; however, unlike previous reports the average PHQ-4 score was higher for medical specialists than for nurses.41,44,45 We did not analyze responses by sex of the medical specialists, and the multivariate analysis also did not show a significant association between these variables.

Besides sex, only a history of depression and having no coping strategies were significantly associated with a high level of depression/anxiety, a result attributable to vulnerability arising from previous depressive episodes,35,46,47 the lack of personal resources to manage mental distress,48 and the exacerbation of mental health symptoms during the pandemic.36

Our study has some limitations. Specifically, the sample size and the sampling method could introduce a selection bias with greater participation in better mental health conditions. In addition, despite the internal consistency indices being similar to those observed in Colombian validations of the instruments used,49–51 these validations have not been done specifically for oncology care providers. Finally, the lack of pretest measures of psychological variables limits further interpretations of our findings. To obtain a significant number of participants, we carried out the study during a 6-month period after the beginning of the national confinement, thus covering a progressive instauration of the pandemic and the end of the first wave in August; it is possible that restricting the study to a shorter period in recent phases of the pandemic would result in different outcomes.51

Despite its limitations, we think our study will be useful in helping design preventive measures during future emergencies with a potential impact on oncology care, given the special and vulnerable condition of oncology patients and the associated stress on oncology care providers. Indeed, we found 46.7% of care providers with a ‘few’ or ‘not at all’ coping strategies indicating a need for oncology care provider education. In general, we believe that growing information about the mental health of oncology care providers allows for better implementation of preventive measures to promote their psychological wellbeing. Furthermore, a complementary approach using mental health parameters objectively during periods with no crises is highly desirable.

Data availability statement

The data that support the findings of this study are openly available in the Open Science Framework (OSF) at https://osf.io/q7dha/?view_only=3e0c8a02ac604b428fa3fd68e261753b, in the folder “Data set”.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Conflicts of interest

The authors have no conflicts of interest to declare.

Appendix A
Supplementary data

The following are the supplementary data to this article:

References
[1]
S. Brown, C. Nwokoro, A. Bush, W. Lenney, J. Vestbo, C. Pao, et al.
Another public health catastrophe.
Lancet, 398 (2021), pp. 2243-2244
[2]
R. Maunder, N. Heeney, A. Kiss, J. Hunter, L. Jeffs, L. Ginty, et al.
Psychological impact of the COVID-19 pandemic on hospital workers over time: relationship to occupational role, living with children and elders, and modifiable factors.
Gen Hosp Psychiatry, 71 (2021), pp. 88-94
[3]
V. Freeman, S. Hughes, C. Carle, D. Campbell, S. Egger, H. Hui, et al.
Are patients with cancer at higher risk of COVID-19-related death?.
J Cancer Policy, 33 (2022), pp. 1-14
[4]
S. Christ, M. Denner, N. Andratschke, P. Balermpas, B. Hilty, S. Tanadini-Lang, et al.
Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic.
Clin Transl Radiat Oncol, 35 (2022), pp. 110-117
[5]
L. Granek, O. Nakash.
Oncology healthcare professionals’ mental health during the COVID-19 pandemic.
Curr Oncol, 29 (2022), pp. 4054-4067
[6]
A.R. Jazieh, A. Coutinho, A. Bensalem, A. Alsharm, H. Errihani, L. Mula-Hussain, et al.
Impact of the COVID-19 pandemic on oncologists: results of an international study.
JCO Glob Oncol, (2021), pp. 7
[7]
S. Moerdler, D. Steinberg, Z. Jin, P. Cole, A. Levy, S. Rosentha.
Well-being of pediatric hematology oncology providers and staff during the COVID-19 pandemic in the New York and New Jersey epicenter.
JCO Oncol Pract, 17 (2021), pp. 925-935
[8]
S. Morassaei, L. Di Prospero, E. Ringdalen, S. Olsen, A. Korsell, D. Erler, et al.
A survey to explore the psychological impact of the COVID-19 pandemic on radiation therapists in Norway and Canada: a tale of two countries.
J Med Radiat Sci, 68 (2021), pp. 407-417
[9]
L. Thomaier, D. Teoh, P. Jewett, H. Beckwith, H. Parsons, J. Yuan, et al.
Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemic.
PLOS ONE, 15 (2020), pp. 1-10
[10]
T. Teixeira, L. Gomes, G. Gasparini, E. De Domenico.
Cancer care in the COVID-19 era and psychosocial impacts on oncology nursing in Brazil.
Ecancermedicalscience, 15 (2021), pp. 1-7
[11]
S. Cohen, T. Kamarck, R. Mermelstein.
A global measure of perceived stress.
J Health Soc Behav, 24 (1983), pp. 385-396
[12]
K. Connor, J. Davidson.
Development of a new resilience scale: the Connor–Davidson resilience scale (CD-RISC).
Depress Anxiety, 18 (2003), pp. 76-82
[13]
L. Wocial, M. Weaver.
Development and psychometric testing of a new tool for detecting moral distress: the moral distress thermometer.
J Adv Nurs, 69 (2013), pp. 167-174
[14]
K. Kroenke, R. Spitzer, J. Williams, B. Löwe.
An ultra-brief screening scale for anxiety and depression: the PHQ-4.
Psychosomatics, 50 (2009), pp. 613-621
[15]
L. Campbell-Sills, M. Stein.
Psychometric analysis and refinement of the Connor–Davidson Resilience Scale (CD-RISC): validation of a 10-item measure of resilience.
J Trauma Stress, 20 (2007), pp. 1019-1028
[16]
S. Muñoz, R. Sánchez, L. del Toro.
Adaptación transcultural al español de la escala Distress Management del NCCN versión 2.2018 para su utilización en pacientes oncológicos en Colombia.
Rev Colomb Cancerol, 23 (2019), pp. 144-151
[17]
A. Al Dhaheri, M. Bataineh, M. Mohamad, A. Ajab, A. Al Marzouqi, A. Jarrar, et al.
Impact of COVID-19 on mental health and quality of life: is there any effect? A cross-sectional study of the MENA region.
PLOS ONE, 16 (2021), pp. 1-17
[18]
C. Castaño, N. Berrío, M. Alba-Marrugo, J.P. Sanchéz, A. Marín-Cortés, W. Tungjitcharoen.
Exploratory study on the mental health of people under isolation during the covid-19 outbreak.
Rev Colomb Psicol, 31 (2022), pp. 27-43
[19]
A. Dawel, Y. Shou, M. Smithson, N. Cherbuin, M. Banfield, A. Calear, et al.
The effect of COVID-19 on mental health and wellbeing in a representative sample of Australian adults.
Front Psychol, 11 (2020), pp. 1-8
[20]
F. Hlubocky, B. Symington, D. McFarland, C. Gallagher, K. Dragnev, J. Burke, et al.
Impact of the COVID-19 pandemic on oncologist burnout, emotional well-being, and moral distress: considerations for the cancer organization's response for readiness, mitigation, and resilience.
JCO Oncol Pract, 17 (2020), pp. 365-374
[21]
L. Mihic-Gongora, P. Jiménez-Fonseca, R. Jiménez-Fonseca, M. Gil-Raga, V. Pacheco-Barcia, A. Manzano-Fernández, et al.
Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality.
BMC Palliat Care, 21 (2022), pp. 1-7
[22]
J. Ramírez-Ortiz, D. Castro-Quintero, C. Lerma-Córdoba, F. Yela-Ceballos, F. Escobar-Córdoba.
Consecuencias de la pandemia de la COVID-19 en la salud mental asociadas al aislamiento social.
Colomb J Anesthesiol, 48 (2020), pp. 1-8
[23]
G. Mertens, L. Gerritsen, S. Duijndam, E. Salemink, I. Engelhard.
Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020.
J Anxiety Disord, 74 (2020), pp. 1-8
[24]
Y. Sahashi, H. Endo, T. Sugimoto, T. Nabeta, K. Nishizaki, A. Kikuchi, et al.
Worries and concerns among healthcare workers during the coronavirus 2019 pandemic: a web-based cross-sectional survey.
Humanit Soc Sci Commun, 8 (2021), pp. 1-23
[25]
A. Shiina, T. Niitsu, O. Kobori, K. Idemoto, T. Hashimoto, T. Sasaki, et al.
Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: a national survey in Japan.
Brain Behav Immun Health, 6 (2020), pp. 1-8
[26]
L. Simione, C. Gnagnarella.
Differences between health workers and general population in risk perception, behaviors, and psychological distress related to COVID-19 spread in Italy.
Front Psychol, 11 (2020), pp. 1-17
[27]
U. Urooj, A. Ansari, A. Siraj, S. Khan, H. Tariq.
Expectations, fears and perceptions of doctors during Covid-19 pandemics.
Pak J Med Sci, 36 (2020), pp. 1-6
[28]
J. Wang, W. Liu, Y. Zhang, S. Xie, B. Yang.
Perceived stress among Chinese medical students engaging in online learning in light of COVID-19.
Psychol Res Behav Manag, 14 (2021), pp. 549-562
[29]
M. Osorio-Martínez, M. Malca-Casavilca, Y. Condor-Rojas, M. Becerra-Bravo, E. Ruiz-Ramirez.
Factores asociados al desarrollo de estrés, ansiedad y depresión en trabajadores sanitarios en el contextode la pandemia por COVID-19 en Perú.
Arch Prev Riesgos Laborales, 25 (2022), pp. 271-284
[30]
R. Alvarado, J. Ramírez, Í. Lanio, M. Cortés, A. Aguirre, P. Bedregal, et al.
El impacto de la pandemia de COVID-19 en la salud mental de los trabajadores de la salud en Chile: datos iniciales de The Health Care Workers Study.
Rev Med Chile, 149 (2021), pp. 1205-1214
[31]
S. Osorio-Anaya, H. Molina-Villar, A. Uribe-Escobar, M.d.C. Ochoa-Martelo.
Efecto de la pandemia por COVID-19 en la salud mental de los otorrinolaringólogos en Hispanoamérica.
Acta Otorrinolaringol Cir Cabeza Cuello, 49 (2021), pp. 121-128
[32]
R. Caruso, W. Breitbart.
Mental health care in oncology. Contemporary perspective on the psychosocial burden of cancer and evidence-based interventions.
Epidemiol Psychiatr Sci, 29 (2020), pp. 1-4
[33]
A. Font, V. Corti, R. Berger.
Burnout in healthcare professionals in oncology.
Proc Econ Finance, 23 (2015), pp. 228-232
[34]
P. Vici, E. Krasniqi, L. Pizzuti, G. Ciliberto, M. Mazzotta, D. Marinelli, et al.
Burnout of health care providers during the COVID-19 pandemic: focus on medical oncologists.
Int J Med Sci, 18 (2021), pp. 2235-2238
[35]
C. Petrisor, C. Breazu, M. Doroftei, I. Maries, C. Popescu.
Association of moral distress with anxiety, depression, and an intention to leave among nurses working in intensive care units during the COVID-19 pandemic.
Healthcare, 9 (2021), pp. 2-13
[36]
N. Ayani, T. Matsuoka, S. Yamano, J. Narumoto.
Depression relapse during long-term remission due to media-amplified fear during the COVID-19 pandemic.
Case Rep Psychiatry, 2021 (2021), pp. 5682611
[37]
S. Banerjee, K.H. Lim, K. Murali, K. Kamposioras, K. Punie, C. Oing, et al.
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration.
ESMO Open, 6 (2021), pp. 1-10
[38]
E. Browning, J. Cruz.
Reflective debriefing: a social work intervention addressing moral distress among ICU nurses.
J Soc Work End Life Palliat Care, 14 (2018), pp. 44-72
[39]
N.I. González-Arratia, J. Valdez.
Resiliencia: diferencias por edad en hombres y mujeres mexicanos.
Acta Investig Psicol, 3 (2013), pp. 941-955
[40]
M. Bansal, A. Jindal, R. Walia, A. Jindal, R. Gupta.
Comparative analysis of depression, anxiety, and stress scores among nurses in different departments from a single center in North India.
Int J Nurs Res, 6 (2020), pp. 149-154
[41]
P. Matud.
Diferencias de género en los síntomas más comunes de salud mental en una muestra de residentes en canarias, España.
Rev Mex Psicol, 22 (2005), pp. 395-403
[42]
I. Jalnapurkar, M. Allen, T. Pigott.
Sex differences in anxiety disorders: a review.
HSOA J Psychiatry Depress Anxiety, 4 (2018), pp. 3-16
[43]
D. Schmidt, R. Dantas, M. Marziale.
Anxiety and depression among nursing professionals who work in surgical units.
Rev Esc Enferm USP, 45 (2011), pp. 487-493
[44]
X.B. Zhang, W. Xiao, J. Lei, M. Li, X. Wang, Y. Hong, et al.
Prevalence and influencing factors of anxiety and depression symptoms among the first-line medical staff in Wuhan mobile cabin hospital during the COVID-19 epidemic.
Medicine (Baltimore), 100 (2021), pp. 1-6
[45]
N. Ghorbani, S. Krauss.
Relationship of perceived stress with depression: complete mediation by perceived control and anxiety in Iran and the United States.
Int J Psychol, 43 (2008), pp. 958-968
[46]
B. Zhang, X. Yan, F. Zhao, F. Yuan.
The relationship between perceived stress and adolescent depression: the roles of social support and gender.
Soc Indic Res, 123 (2014), pp. 501-518
[47]
M. Drapeau, E. Blake, K. Dobson, A. Körner.
Coping strategies in major depression and over the course of cognitive therapy for depression.
Can J Couns Psychother, 51 (2017), pp. 18-39
[48]
A. Campo-Arias, G.J. Bustos-Leiton, A. Romero-Chaparro.
Consistencia interna y dimensionalidad de la Escala de Estrés Percibido (EEP-10 y EEP-14) en una muestra de universitarias de Bogotá, Colombia.
Aquichan, 9 (2009), pp. 271-280
[49]
R.D. Kocalevent, C. Finck, W. Jimenez-Leal, L. Sautier, A. Hinz.
Standardization of the Colombian version of the PHQ-4 in the general population.
BMC Psychiatry, 14 (2014), pp. 1-8
[50]
F. Riveros, L. Bernal, D. Bohórquez, S. Vinaccia, J. Quiceno.
Análisis psicométrico del Connor–Davidson Resilience Scale (CD-RISC 10) en población universitaria colombiana.
Psicol Desde El Caribe, 34 (2017), pp. 161-171
[51]
K.H. Lim, K. Murali, K. Kamposioras, K. Punie, C. Oing, M. O’Connor, et al.
The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.
ESMO Open, 6 (2021), pp. 1-9
Copyright © 2023. Asociación Colombiana de Psiquiatría
Opciones de artículo
Herramientas
Material suplementario